FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2401979616> ?p ?o ?g. }

• W2401979616 endingPage "123" @default.
• W2401979616 startingPage "115" @default.
• W2401979616 abstract "Late-onset Pompe disease is characterized by progressive skeletal myopathy followed by respiratory muscle weakness, typically leading to loss of ambulation and respiratory failure. In this population, enzyme replacement therapy (ERT) with alglucosidase alfa has been shown to stabilize respiratory function and improve mobility and muscle strength. Muscle pathology and glycogen clearance from skeletal muscle in treatment-naïve adults after ERT have not been extensively examined. This exploratory, open-label, multicenter study evaluated glycogen clearance in muscle tissue samples collected pre- and post- alglucosidase alfa treatment in treatment-naïve adults with late-onset Pompe disease. The primary endpoint was the quantitative reduction in percent tissue area occupied by glycogen in muscle biopsies from baseline to 6 months. Secondary endpoints included qualitative histologic assessment of tissue glycogen distribution, secondary pathology changes, assessment of magnetic resonance images (MRIs) for intact muscle and fatty replacement, and functional assessments. Sixteen patients completed the study. After 6 months of ERT, the percent tissue area occupied by glycogen in quadriceps and deltoid muscles decreased in 10 and 8 patients, respectively. No changes were detected on MRI from baseline to 6 months. A majority of patients showed improvements on functional assessments after 6 months of treatment. All treatment-related adverse events were mild or moderate. This exploratory study provides novel insights into the histopathologic effects of ERT in late-onset Pompe disease patients. Ultrastructural examination of muscle biopsies demonstrated reduced lysosomal glycogen after ERT. Findings are consistent with stabilization of disease by ERT in treatment-naïve patients with late-onset Pompe disease." @default.
• W2401979616 created "2016-06-24" @default.
• W2401979616 creator A5003553984 @default.
• W2401979616 creator A5012227405 @default.
• W2401979616 creator A5014378465 @default.
• W2401979616 creator A5023248855 @default.
• W2401979616 creator A5025781296 @default.
• W2401979616 creator A5032923167 @default.
• W2401979616 creator A5039404447 @default.
• W2401979616 creator A5046451291 @default.
• W2401979616 creator A5051045476 @default.
• W2401979616 creator A5051766803 @default.
• W2401979616 creator A5061008360 @default.
• W2401979616 creator A5064026979 @default.
• W2401979616 creator A5067117784 @default.
• W2401979616 creator A5067876029 @default.
• W2401979616 creator A5075931186 @default.
• W2401979616 creator A5081830433 @default.
• W2401979616 creator A5083732820 @default.
• W2401979616 creator A5087761286 @default.
• W2401979616 creator A5088683724 @default.
• W2401979616 creator A5089031060 @default.
• W2401979616 creator A5089683798 @default.
• W2401979616 creator A5089772872 @default.
• W2401979616 date "2016-09-01" @default.
• W2401979616 modified "2023-10-18" @default.
• W2401979616 title "Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study" @default.
• W2401979616 cites W1585579342 @default.
• W2401979616 cites W1786920819 @default.
• W2401979616 cites W1965744154 @default.
• W2401979616 cites W1973362990 @default.
• W2401979616 cites W1973735640 @default.
• W2401979616 cites W1984537784 @default.
• W2401979616 cites W1987902896 @default.
• W2401979616 cites W2001805850 @default.
• W2401979616 cites W2002294501 @default.
• W2401979616 cites W2006520750 @default.
• W2401979616 cites W2013759235 @default.
• W2401979616 cites W2018278507 @default.
• W2401979616 cites W2024973716 @default.
• W2401979616 cites W2025560131 @default.
• W2401979616 cites W2027671694 @default.
• W2401979616 cites W2041506647 @default.
• W2401979616 cites W2041793850 @default.
• W2401979616 cites W2047627643 @default.
• W2401979616 cites W2050957628 @default.
• W2401979616 cites W2055655054 @default.
• W2401979616 cites W2094188127 @default.
• W2401979616 cites W2095643828 @default.
• W2401979616 cites W2097541847 @default.
• W2401979616 cites W2099289539 @default.
• W2401979616 cites W2100033085 @default.
• W2401979616 cites W2100199292 @default.
• W2401979616 cites W2111298986 @default.
• W2401979616 cites W2115074653 @default.
• W2401979616 cites W2132424400 @default.
• W2401979616 cites W2134392644 @default.
• W2401979616 cites W2135690636 @default.
• W2401979616 cites W2144392873 @default.
• W2401979616 cites W2154167928 @default.
• W2401979616 cites W2155934793 @default.
• W2401979616 cites W2159490726 @default.
• W2401979616 cites W2167525501 @default.
• W2401979616 cites W2312012050 @default.
• W2401979616 doi "https://doi.org/10.1016/j.ymgme.2016.05.013" @default.
• W2401979616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27473031" @default.
• W2401979616 hasPublicationYear "2016" @default.
• W2401979616 type Work @default.
• W2401979616 sameAs 2401979616 @default.
• W2401979616 citedByCount "44" @default.
• W2401979616 countsByYear W24019796162017 @default.
• W2401979616 countsByYear W24019796162018 @default.
• W2401979616 countsByYear W24019796162019 @default.
• W2401979616 countsByYear W24019796162020 @default.
• W2401979616 countsByYear W24019796162021 @default.
• W2401979616 countsByYear W24019796162022 @default.
• W2401979616 countsByYear W24019796162023 @default.
• W2401979616 crossrefType "journal-article" @default.
• W2401979616 hasAuthorship W2401979616A5003553984 @default.
• W2401979616 hasAuthorship W2401979616A5012227405 @default.
• W2401979616 hasAuthorship W2401979616A5014378465 @default.
• W2401979616 hasAuthorship W2401979616A5023248855 @default.
• W2401979616 hasAuthorship W2401979616A5025781296 @default.
• W2401979616 hasAuthorship W2401979616A5032923167 @default.
• W2401979616 hasAuthorship W2401979616A5039404447 @default.
• W2401979616 hasAuthorship W2401979616A5046451291 @default.
• W2401979616 hasAuthorship W2401979616A5051045476 @default.
• W2401979616 hasAuthorship W2401979616A5051766803 @default.
• W2401979616 hasAuthorship W2401979616A5061008360 @default.
• W2401979616 hasAuthorship W2401979616A5064026979 @default.
• W2401979616 hasAuthorship W2401979616A5067117784 @default.
• W2401979616 hasAuthorship W2401979616A5067876029 @default.
• W2401979616 hasAuthorship W2401979616A5075931186 @default.
• W2401979616 hasAuthorship W2401979616A5081830433 @default.
• W2401979616 hasAuthorship W2401979616A5083732820 @default.
• W2401979616 hasAuthorship W2401979616A5087761286 @default.
• W2401979616 hasAuthorship W2401979616A5088683724 @default.
• W2401979616 hasAuthorship W2401979616A5089031060 @default.

• next